Earlier diagnosis may finally be within reach for Alzheimer’s disease. Gary Zammit, PhD, Forbes Books author, examines this FDA breakthrough and why refocusing trials around patients is critical to real progress.

Back to News

When you need to get your product to the people who need it most, your pathway to CNS approval starts with Clinilabs.

Get in Touch
Clinilabs Pre-Footer Image